Form 8-K - Current report:
SEC Accession No. 0001193125-25-053552
Filing Date
2025-03-13
Accepted
2025-03-13 09:12:59
Documents
16
Period of Report
2025-03-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d927002d8k.htm   iXBRL 8-K 43789
2 EX-3.1 d927002dex31.htm EX-3.1 24009
3 EX-4.1 d927002dex41.htm EX-4.1 309816
4 EX-99.1 d927002dex991.htm EX-99.1 18038
  Complete submission text file 0001193125-25-053552.txt   615120

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA slrn-20250312.xsd EX-101.SCH 2841
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE slrn-20250312_lab.xml EX-101.LAB 18723
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slrn-20250312_pre.xml EX-101.PRE 11698
19 EXTRACTED XBRL INSTANCE DOCUMENT d927002d8k_htm.xml XML 3873
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-456-4393
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

EIN.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41696 | Film No.: 25734015
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)